Upgrade to SI Premium - Free Trial

Enlivex cuts 60% of workforce to focus on knee OA trial

October 19, 2026 8:17 AM
Enlivex Ltd. (NASDAQ: ENLV) announced a cost reduction plan, effective immediately, that includes cutting approximately 60% of its workforce and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA